Skip to main content
Alexi Wright, MD, Oncology, Boston, MA

Alexi Anne Wright MD MPH

Gynecologic Cancer, Hematologic Oncology


Associate Professor, Harvard Medical School Medical Oncologist, Dana-Farber Cancer Institute

Join to View Full Profile
  • 450 Brookline AveBoston, MA 02215

  • Phone+1 617-632-2334

  • Fax+1 617-632-3479

Dr. Wright is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2005 - 2026
  • CT State Medical License
    CT State Medical License 2022 - 2025
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors
    Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and DoctorsSeptember 10th, 2024
  • Study Finds ‘Startling’ Inequities in End-of-Life Opioid Treatment
    Study Finds ‘Startling’ Inequities in End-of-Life Opioid TreatmentJanuary 17th, 2023
  • Studies Show That Laws to Limit Opioid Prescribing Have Hampered Pain Control for Patients with Cancer
    Studies Show That Laws to Limit Opioid Prescribing Have Hampered Pain Control for Patients with CancerFebruary 25th, 2022
  • Join now to see all

Grant Support

  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • A multi-level examination of the influences of racism on cancer pain equityDANA-FARBER CANCER INST2024–2029
  • Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitorsDANA-FARBER CANCER INST2024–2029
  • BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Gynecologic and Gastrointestinal Cancers - a Multi-Site Randomized Controlled TrialDANA-FARBER CANCER INST2023–2028
  • BOLSTER: Strengthening Patient and Caregiver Supports in Advanced Gynecologic and Gastrointestinal Cancers - a Multi-Site Randomized Controlled TrialDANA-FARBER CANCER INST2023–2028

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: